Order Article Reprints

Radhwi OO, Jan H, Waheeb A, Alamri SS, Alahwal HM, Denetiu I, Almanzlawey A, Al-Marzouki AF, Almohammadi AT, Bahashwan SM, et al. Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies. Vaccines. 2022; 10(2):151. https://doi.org/10.3390/vaccines10020151

Radhwi, Osman O., Hamza Jan, Abdullah Waheeb, Sawsan S. Alamri, Hatem M. Alahwal, Iuliana Denetiu, Ashgan Almanzlawey, Adel F. Al-Marzouki, Abdullah T. Almohammadi, Salem M. Bahashwan, and et al. 2022. "Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies" Vaccines 10, no. 2: 151. https://doi.org/10.3390/vaccines10020151

Radhwi, O. O., Jan, H., Waheeb, A., Alamri, S. S., Alahwal, H. M., Denetiu, I., Almanzlawey, A., Al-Marzouki, A. F., Almohammadi, A. T., Bahashwan, S. M., Barefah, A. S., Qari, M. H., Abuzenadah, A. M., & Hashem, A. M. (2022). Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies. Vaccines, 10(2), 151. https://doi.org/10.3390/vaccines10020151